Neogen Chemicals
NEOGEN · NSE · Chemicals · India
Financials at a glance
Source: Yahoo FinanceAnnual
Quarterly · last 5
Revenue (FY2026)
₹862 Cr
Net margin
3.3%
Revenue CAGR (3y)
+7.9%
Profit CAGR (3y)
-16.8%
Net profit (FY2026)
₹29 Cr
Ask MarketChacha about NEOGEN
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Aug 5, 2026
Neogen Chemicals fell on concerns around the proposed ₹600 crore QIP fundraising (approved by the board in late July and up for shareholder vote at the Aug 21 AGM), which raises dilution fears; no fresh catalyst appeared on Aug 5 and the stock moved with broader specialty chemicals sentiment.
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | Net margin |
|---|---|---|---|
| FY2026 | ₹862 Cr | ₹29 Cr | 3.3% |
| FY2025 | ₹778 Cr | ₹35 Cr | 4.5% |
| FY2024 | ₹691 Cr | ₹36 Cr | 5.2% |
| FY2023 | ₹686 Cr | ₹50 Cr | 7.3% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| Q1 FY27 | ₹250 Cr | ₹17 Cr | 6.29 | 6.8% |
| Q4 FY26 | ₹247 Cr | ₹11 Cr | — | 4.6% |
| Q3 FY26 | ₹220 Cr | ₹4 Cr | — | 1.7% |
| Q2 FY26 | ₹209 Cr | ₹3 Cr | — | 1.6% |
| Q1 FY26 | ₹187 Cr | ₹10 Cr | — | 5.5% |
Figures as reported, in ₹ (crore). Source: Yahoo Finance.
Filings & announcements
2026
Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.
BSE8/31/2026Disclosure pursuant to regulation 7(2) of SEBI PIT Regulations.
BSE8/29/2026Submission Of Consolidated Voting Results And Scrutinizer''''s Report Of The 37Th AGM.
Submission of Consolidated Voting Results and Scrutinizer''s Report of the 37th AGM.
BSE8/22/2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Consolidated Voting Results and Scrutinizer''s Report of the 37th AGM.
BSE8/22/2026materialShareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 37th AGM.
BSE8/21/2026materialDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
BSE8/20/2026Earnings Call Transcript - Q1FY27
BSE8/1/2026Business Responsibility and Sustainability Reporting (BRSR)
BRSR and BRSR Assurance Report FY 2025-26.
BSE7/30/2026Notice Of 37Th AGM And Integrated Annual Report For FY 2025-26
Notice of 37th AGM and Integrated Annual Report for FY 2025-26.
BSE7/30/2026materialIntegrated Report for F.Y. 2025-26
BSE7/30/2026Outcome Of Analysts/ Investors Conference Call - Call Recording.
Outcome of Analysts/ Investors Conference Call - Call Recording.
BSE7/27/2026Earnings presentation on unaudited results for Q1FY2027.
BSE7/26/2026Press Release on unaudited results for Q1FY27.
BSE7/26/2026Revised Statement of Deviation/ Variation .
BSE7/24/2026Revised Statement Of Deviation/Variation
Revised Statement of Deviation/ Variation
BSE7/24/2026Monitoring Agency report and Statement of Deviation/ variation.
BSE7/24/2026Statement Of Deviation/ Variation And Monitoring Agency Report
Statement of Deviation & Variation and Monitoring Agency report
BSE7/24/2026Appointment of Internal Auditors for FY 2026-27
BSE7/24/2026Qualified Institutional Placement
Granting of Inprinciple approval for raising of funds upto 600 crore.
BSE7/24/2026Approval of financials for the quarter ended 30-06-2026, statement of deviation / variation, approved integrated annual report for fy 2025-26, fixing cut off date and book closure period, ....
BSE7/24/2026Approval of Record date and Book closure period.
BSE7/24/2026Inprinciple approval for raising of funds upto 600 crore.
BSE7/24/2026Financial Results For The Quarter Ended June 30,2026.
Unaudited Financial Results for the quarter ended June 30, 2026
BSE7/24/2026Board Meeting Outcome for Outcome Of Board Meeting Held On 24-07-2026
Approval of financials for the quarter ended June 30,2026, Statement of Deviation/ variation, Approval of Integrated Report for FY 2025-26, fixing of cut off date and book closure date ....
BSE7/24/2026
In the news
- Neogen Chemicals arm to transfer LiPF6 business to step-down subsidiary for ₹245 croreCNBC TV18 · 8/31/2026
- Neogen Chemicals approves ₹245 crore inter-subsidiary business transferscanx.trade · 8/31/2026
- Top Chemicals Stocks: High Promoter Holding ListUnivest · 8/31/2026
- Neogen Chemicals: Heena Reshamwala gifts 354 shares off-marketscanx.trade · 8/29/2026
- Three stocks with target price and stop loss: Brokerage recommends them for quick gainsNews9live · 8/28/2026
- 5 Lithium Stocks India 2026: Strong Future RoadmapsUnivest · 8/27/2026
- Neogen Chemicals Ltd. Key Financial Ratios – Valuation, Profitability & MoreValue Research · 8/27/2026
- Neogen Chemicals shareholders approve ₹1 dividend, fund raise at AGMscanx.trade · 8/21/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.